MedPath

Evaluation of Human Efficacy of SOD Like Super Drink

Not Applicable
Completed
Conditions
Dermatology
Registration Number
NCT06322589
Lead Sponsor
TCI Co., Ltd.
Brief Summary

To assess the efficacy of SOD like Super Drink on anti-oxidant capacity, immuno regulation and skin for human

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • healthy adults aged between 30-65 years old
Exclusion Criteria
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder
  • Patients with diseases of the skin, liver, kidney.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 4 weeks.
  • Students who are currently taking courses taught by the principal investigator of this trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
the change of Glutathione (GSH) of bloodChange from Baseline GSH at 8 weeks

venous blood was sampled to measure GSH

the change of Superoxide Dismutase (SOD) of bloodChange from Baseline SOD at 8 weeks

venous blood was sampled to measure SOD

the roughness of skin textureRating skin roughness from Baseline skin texture at 8 weeks

IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units

the change of skin elasticityChange from Baseline skin elasticity at 8 weeks

Cutometer® was utilized to measure skin elasticity. Units: arbitrary units

the change of Total Anti-oxidative Capacity (TAC) of bloodChange from Baseline TAC at 8 weeks

venous blood was sampled to measure TAC

the change of Glutathione S-transferase (GST) of bloodChange from Baseline GST at 8 weeks

venous blood was sampled to measure GST

the volume of skin wrinklesVolume change from Baseline skin wrinkles at 8 weeks

IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units

the change of Malondialdehyde (MDA) of bloodChange from Baseline MDA at 8 weeks

venous blood was sampled to measure MDA

the change of immune-related cytokines of bloodChange from Baseline immune-related cytokines at 8 weeks

venous blood was sampled to measure immune-related cytokines

Secondary Outcome Measures
NameTimeMethod
the change of skin Transepidermal Water Loss (TEWL)Change from Baseline TEWL at 8 week

Tewameter® TM 300 was utilized to measure TEWL. Units: arbitrary units

the change of skin surface hydrationChange from Baseline skin surface hydration at 8 week

Corneometer® CM 825 was utilized to measure skin surface hydration. Units: arbitrary units

the change of Skin Erythema IndexChange from Baseline skin Erythema Index at 8 week

Mexameter® MX 18was utilized to measure skin Erythema Index. Units: arbitrary units

the change of Skin Melanin IndexChange from Baseline skin Melanin Index at 8 week

Mexameter® MX 18was utilized to measure Melanin Index. Units: arbitrary units

Trial Locations

Locations (1)

China Medical University of department of cosmeceutics

🇨🇳

Taichung City, Taiwan

China Medical University of department of cosmeceutics
🇨🇳Taichung City, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.